MetaCap

ProMIS Neurosciences Inc. Company Profile

NASDAQ: PMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.16-0.05 (-1.56%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ProMIS Neurosciences at a glance

ProMIS Neurosciences Inc. (NASDAQ: PMN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Toronto, ON, Canada. ProMIS Neurosciences is led by Mr. Neil K. Warma M.B.A. and employs about 10 people. At a market capitalization of $28.9 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001374339, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does ProMIS Neurosciences do?

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.

Business description based on the company's public filings.

Company information

Legal name
ProMIS Neurosciences Inc.
Ticker
NASDAQ: PMN
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Neil K. Warma M.B.A.
Employees
10
Headquarters
1920 Yonge Street, Toronto, ON, Canada
Phone
416 847 6898
Market cap
$28.88M
SEC CIK
0001374339
Latest annual report
10-K · Mar 25, 2026

Companies similar to ProMIS Neurosciences

PMN peer companies
CompanyPrice% ChgMarket capCompare
AYTUAytu BioPharma Inc.2.660.00%$28.91Mvs PMN
ATHEAlterity Therapeutics Limited ADR1.52-8.16%$29.02Mvs PMN
RNTXRein Therapeutics Inc.0.3369-8.38%$29.06Mvs PMN
NNVCNanoViricides Inc.1.14-2.56%$29.13Mvs PMN
NXTCNextCure Inc.6.45-4.87%$29.53Mvs PMN
SERSerina Therapeutics Inc.1.12-6.67%$29.76Mvs PMN
EDSAEdesa Biotech Inc.2.00-8.05%$27.02Mvs PMN
NSRXNasus Pharma Ltd.2.29-10.20%$26.82Mvs PMN

Related